Engineering/Applied Physics Intern
About the job
- Strong fundamentals in both a scientific (physics, chemistry, biology) and an engineering (electrical, mechanical, computational) discipline
- Recently finished or working towards degree in Electrical Engineering, Mechanical Engineering, Physics, or equivalent
- Ability to work for minimum 3 full months
- Demonstrations of exceptional ability and autonomy in past work
About the company
UntilLabs develops reversible cryopreservation technology to extend the viability of human organs for transplantation. The goal is to keep organs alive at cryogenic temperatures long enough to improve organ matching and reduce waste from time limits, potentially weeks or months of preserved time. The approach uses cooling to very low temperatures (below -130°C) with cryoprotectants to prevent ice damage, followed by advanced warming methods to revive the organs without harm. While cryopreservation has worked for cells and simple tissues, UntilLabs works on scaling this to whole organs, tackling challenges like ice formation and nutrient/waste management in large tissues. In the long term, the company envisions whole-body reversible cryopreservation as a bridge to future medical cures.
Company Size
51-200
Company Stage
Series A
Total Funding
$58M
Headquarters
San Francisco, CA
Founded
2024
Get referred to UntilLabs
See people who can refer or advise you
Simplify's Take
What believers are saying
- 2026 hiring spans perfusion, cardiac biology, and organ perfusion, signaling active R&D expansion.
- Pig organ isolation and ex-vivo evaluation roles suggest near-term preclinical organ validation.
- The 2026 patent strengthens defensibility around cryoprotectants, vitrification, and rewarming hardware.
What critics are saying
- X-Therma already has FDA Breakthrough status and 120-hour kidney preservation claims.
- Until still has no public human transplant data, leaving commercialization unproven.
- Whole-body cryopreservation messaging invites regulatory scrutiny and distracts from organ preservation execution.
What makes UntilLabs unique
- Founders Fund, Lux, and Field backed Until Labs' 2025 $58M Series A.
- Until's 2026 site says it has raised $100M+ and is hiring.
- Its patent for reversible cryopreservation covers perfusion, pressure, and volumetric rewarming.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- Flexible Work Hours
- Paid Holidays
- 401(k) Retirement Plan
- Health Savings Account/Flexible Spending Account
- Commuter Benefits
- Professional Development Budget